Biocept, Inc. announces the pricing of an underwritten public offering of 1,176,470 shares of its common stock and warrants to purchase up to an aggregate of 2,352,940 shares of its common stock at a combined offering price of $4.25 per share and an accompanying warrant to purchase two shares of common stock.
